Home/General Oncology/Arnold Glazier, M.D.
AG

Arnold Glazier, M.D.

Chief Scientific Officer

General Oncology

Therapeutic Areas

General Oncology Pipeline

DrugIndicationPhase
GO-4305CMetastatic cancers, including BRCA-associated pancreatic ductal adenocarcinomaPhase 1
GO-2301Wet age-related macular degeneration (AMD) and diabetic retinopathyPreclinical